Neil F. McFarlane
President and Chief Executive Officer
CEO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Zevra Therapeutics, Inc. (ZVRA) | President, Chief Executive Officer and Director | $729,167 | $3,782,042 |
| 2024 | Zevra Therapeutics, Inc. (ZVRA) | President, Chief Executive Officer and Director | $700,000 | $5,355,059 |
| 2023 | Zevra Therapeutics, Inc. (ZVRA) | President, Chief Executive Officer and Director | $157,500 | $3,445,231 |
Executive changes
Earnings-call appearances
-
CG 46th Annual Growth Conference2026-08-11
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q2 FY2026 Earnings Call2026-08-05
Zevra Therapeutics, Inc. (ZVRA)
-
H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ2026-05-19
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q1 FY2026 Earnings Call2026-05-06
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q4 FY2025 Earnings Call2026-03-09
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q3 FY2025 Earnings Call2025-11-05
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q2 FY2025 Earnings Call2025-08-12
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q1 FY2025 Earnings Call2025-05-13
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q4 FY2024 Earnings Call2025-03-11
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q3 FY2024 Earnings Call2024-11-12
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q2 FY2024 Earnings Call2024-08-08
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q1 FY2024 Earnings Call2024-05-08
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q4 FY2023 Earnings Call2024-03-28
Zevra Therapeutics, Inc. (ZVRA)
-
Zevra Therapeutics, Inc. Q3 FY2023 Earnings Call2023-11-07
Zevra Therapeutics, Inc. (ZVRA)